DADC
AEMD icon

D.A. Davidson & Co’s Aethlon Medical AEMD Stock Holding History

D.A. Davidson & Co’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14
Closed -$22K – 1188
2021
Q1 		$22K Buy
+14
New +$26.9K ﹤0.01% 1147
2019
Q4 		– Sell
-1
Closed -$2K – 1032
2019
Q3 		$2K Hold
1
– – ﹤0.01% 1002
2019
Q2 		$4K Hold
1
– – ﹤0.01% 991
2019
Q1 		$10K Hold
1
– – ﹤0.01% 1133
2018
Q4 		$18K Hold
1
– – ﹤0.01% 1087
2018
Q3 		$12K Hold
1
– – ﹤0.01% 1160
2018
Q2 		$14K Hold
1
– – ﹤0.01% 1116
2018
Q1 		$14K Hold
1
– – ﹤0.01% 1099
2017
Q4 		$13K Buy
+1
New +$12.2K ﹤0.01% 1107
2017
Q3 		– Hold
0
– -$3K – 1087
2017
Q2 		– Hold
0
– – – 2257
2017
Q1 		– Hold
0
– – – 2160

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

D.A. Davidson & Co's AEMD Position: Q2 2021 in Review

D.A. Davidson & Co sold out of Aethlon Medical (AEMD) in Q2 2021, closing a stake of 14 shares — an estimated $22K sold.

D.A. Davidson & Co first reported a position in AEMD in Q4 2017 and held it in 9 quarters. The position peaked at $22K in Q1 2021. 16 funds tracked by Wall St. Rank hold AEMD as of Q2 2021.

  • D.A. Davidson & Co reported no remaining Aethlon Medical position as of Q2 2021 after selling out during the quarter.
  • D.A. Davidson & Co sold 14 Aethlon Medical shares in Q2 2021, an estimated $22K.
  • D.A. Davidson & Co first reported a position in Aethlon Medical in Q4 2017 and held it in 9 quarters.
  • D.A. Davidson & Co's Aethlon Medical position peaked at $22K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2021.

Based on D.A. Davidson & Co's 13F filing for Q2 2021, filed 10 Aug 2021.